Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

The use of isoenzyme-selective phosphodiesterase (PDE) inhibitors is considered a great opportunity to treat various diseases of the human urogenital tract.

Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the ...

Stepping down to as-needed ICS/FABA maintained asthma stability while significantly reducing steroid exposure in individuals ...

Learn more about the interesting connections between the brain and heart culminating in mast cell activation and development of Kounis syndrome.